Hope for tackling deadly bacterial disease
The fight against melioidosis - a neglected, often fatal, bacterial disease.
Faster, effective and safer gene engineering
Meet Valentina Migliori, a researcher working to make lab science more relevant to clinical research.
Genomics gets faster, cheaper, and more accurate
Four new platforms have been added to one of the world’s largest genome sequencing facilities at the Wellcome Sanger Institute. increasing the speed, capacity and precision of DNA and RNA sequencing.
Meet Professor Tulio de Oliveira, forging a genomic surveillance partnership
As head of the largest genomics institute in Africa and the Genomic Surveillance Unit’s new deputy director, Professor Tulio de Oliveira hopes close collaboration can be “world changing.”
From bench to bedside – Innovating blood cancer clinical practice
We spoke to Jyoti Nangalia, a researcher at the forefront of innovation in blood cancers. She is combining her clinical and academic expertise to bring better diagnosis tools for patients and clinicians.
Tackling trypanosomiasis in cattle in sub-Saharan Africa
Three vaccine targets discovered by the Wellcome Sanger Institute focus on targeting animal trypanosomiasis in an effort to find a cure for a disease that causes billions in economic losses in one of the poorest regions on earth. These losses fall heavily on small holders, who are often heavily dependent on livestock for their livelihood.
2024 Winners: Accelerator Awards for Postdocs
Meet the four winners of our Sanger Accelerator Awards for Postdocs (SAAPs) to accelerate postdocs along their career trajectory
Hacking for the single-cell universe
A recent hackathon, hosted by the Wellcome Sanger Institute, brought together software developers and computational biologists working on tools to analyse data from single cells.
Nine billion and counting – Mapping the human variants and their effects on health and disease
The Atlas of Variant Effects Alliance celebrates its fourth year this month. A collaboration of multiple institutes, including the Wellcome Sanger Institute, the Alliance has the aim of assessing the effects of all variants in our genomes. In this blog, we highlight the Alliance’s achievements and the diverse community underpinning such a colossal effort.
